What is Agelessrx?
AgelessRx is dedicated to advancing healthspan and wellness through science-backed longevity treatments. The company offers a range of products, including Metformin and NAD+ supplements, designed to address diverse health needs such as weight management, cardiovascular health, and cognitive function. By prioritizing research and adhering to expert medical protocols, AgelessRx aims to democratize access to effective longevity science, providing clients with fast delivery and continuous support to empower their health journeys.
How much funding has Agelessrx raised?
Agelessrx has raised a total of $5.5M across 1 funding round:
Private Equity
$5.5M
Private Equity (2026): $5.5M, investors not publicly disclosed
What's next for Agelessrx?
The substantial enterprise-level funding, highlighted by a recent major strategic investment, positions AgelessRx for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development into novel longevity treatments, enhance operational capabilities, and broaden the company's reach within the rapidly evolving wellness industry. AgelessRx is poised to solidify its leadership in making advanced longevity science accessible and actionable for a wider consumer base.
See full Agelessrx company page
